Associated Papers
Impact of Age-3 Urine Screening on Diagnosis and Treatment Timing in Alport Syndrome.
Kitakado H et al.
Kidney International Reports, 2025
41426028 (PubMed )
Supplement: mmc1.pdf
Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene.
Sun L et al.
Stem Cell Research, 2020
Select a paper to view details